NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress
Toronto, Ontario–(Newsfile Corp. – January 16, 2026) – NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen” or the “Company“), a leader in needle-free subcutaneous drug-delivery technology, is providing a summary of key developments achieved during 2025 […]
